Clinical diagnostic utility of CA 15-3 for the diagnosis of malignant pleural effusion: A meta-analysis. [PDF]
Exp Ther Med, 2015 Wu Q, Li M, Zhang S, Chen L, Gu X, Xu F.
europepmc +1 more source
Course of SP-D, YKL-40, CCL18 and CA 15-3 in adult patients hospitalised with community-acquired pneumonia and their association with disease severity and aetiology: A post-hoc analysis. [PDF]
PLoS One, 2018 Spoorenberg SMC +9 more
europepmc +1 more source
Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients. [PDF]
BMC Cancer, 2016 Darlix A +7 more
europepmc +1 more source
A Giant Simple Liver Cyst That Caused Increases in Serum CA 19-9 and CA 15-3 Levels. [PDF]
J Clin Med Res, 2014 Dinc B, Mesci A, Dinc SE, Oskay A.
europepmc +1 more source
Concordance of Hypermethylated DNA and the Tumor Markers CA 15-3, CEA, and TPA in Serum during Monitoring of Patients with Advanced Breast Cancer. [PDF]
Biomed Res Int, 2015 Kristiansen S +4 more
europepmc +1 more source
Cancer Antigen 15-3 (CA 15-3): A Paradigm of Biomarker Utility in Oncology
International Journal of Science and Research (IJSR)Shraddha Prabhu Aditi Palav +2 more
openaire +1 more source
Diagnostic and prognostic role of preoperative circulating CA 15-3, CA 125, and beta-2 microglobulin in renal cell carcinoma. [PDF]
Dis Markers, 2014 Lucarelli G +11 more
europepmc +1 more source
Combined measurement of CA 15-3 with novel autoantibodies improves diagnostic accuracy for breast cancer. [PDF]
Onco Targets Ther, 2013 Dong X +6 more
europepmc +1 more source
The tetrad BMI, leptin, leptin/adiponectin (L/A) ratio and CA 15-3 are reliable biomarkers of breast cancer. [PDF]
J Clin Lab Anal, 2013 Santillán-Benítez JG +6 more
europepmc +1 more source
Evaluation of interleukins 8 and 12, CA 15-3 and free circulating DNA as prognostic markers in dogs with mammary tumors [PDF]
BMC Proc, 2013 Gelaleti G +10 more
europepmc +1 more source